In this context, SCLC has been reported as a high-glycolytic type of tumor, since it displays overexpression of the common metabolic markers of glycolysis (i.e., PKM1 and LDHA) [35,36,37]. This evidence concerns the gene LDHA and small cell lung carcinoma.